awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q54942652-F23F87D7-E262-4D03-AECB-7DCB38F2ECAB
Q54942652-F23F87D7-E262-4D03-AECB-7DCB38F2ECAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54942652-F23F87D7-E262-4D03-AECB-7DCB38F2ECAB
Trends in Malignant Glioma Monoclonal Antibody Therapy.
P2860
Q54942652-F23F87D7-E262-4D03-AECB-7DCB38F2ECAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54942652-F23F87D7-E262-4D03-AECB-7DCB38F2ECAB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83c2e739db06c7c49175086437acfda2ca81a1dc
P2860
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.